1. Home
  2. HPE vs IQV Comparison

HPE vs IQV Comparison

Compare HPE & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hewlett Packard Enterprise Company

HPE

Hewlett Packard Enterprise Company

HOLD

Current Price

$27.40

Market Cap

32.7B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$159.54

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HPE
IQV
Founded
1939
1982
Country
United States
United States
Employees
N/A
93000
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7B
28.6B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
HPE
IQV
Price
$27.40
$159.54
Analyst Decision
Buy
Strong Buy
Analyst Count
19
16
Target Price
$26.82
$227.13
AVG Volume (30 Days)
12.7M
1.2M
Earning Date
06-02-2026
05-05-2026
Dividend Yield
1.99%
N/A
EPS Growth
N/A
4.67
EPS
0.31
7.84
Revenue
$34,296,000,000.00
$9,739,000,000.00
Revenue This Year
$20.37
$6.77
Revenue Next Year
$5.67
$5.89
P/E Ratio
$92.66
$20.85
Revenue Growth
13.84
41.60
52 Week Low
$15.71
$134.65
52 Week High
$29.63
$247.05

Technical Indicators

Market Signals
Indicator
HPE
IQV
Relative Strength Index (RSI) 61.75 37.34
Support Level $20.19 N/A
Resistance Level $29.63 $181.95
Average True Range (ATR) 0.96 5.77
MACD 0.15 -1.22
Stochastic Oscillator 62.82 12.45

Price Performance

Historical Comparison
HPE
IQV

About HPE Hewlett Packard Enterprise Company

Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: